Literature DB >> 16648910

Dissecting the role of infections in atopic dermatitis.

Tilo Biedermann1.   

Abstract

In patients with atopic dermatitis the skin is highly susceptible to infection by bacteria, fungi and viruses. Increasing knowledge about the complex immune network that regulates anti-microbial responses has helped to dissect further the role of infections in atopic dermatitis. Conserved patterns of microbes are recognized by the innate immune system, which mediates microbicidal activity, either directly or through inflammatory responses. New evidence suggests that components of the innate immune system, such as anti-microbial peptides, humoural lectins, nucleotide-binding oligomerization domain-containing (NOD) proteins, and Toll-like receptors not only protect from microbial invasion, but contribute to skin inflammation in atopic dermatitis. In addition, atopic patients tend to develop Th2-dominated immune responses that weaken anti-microbial immunity. This impairment of an appropriate anti-microbial defence compounded by amplified microbe-driven innate and adaptive immune responses leads to the vicious circle of skin inflammation. New microbial management in atopic dermatitis will foster a well-balanced microbial flora, which establishes natural defence mechanisms to maintain immuno-surveillance of the skin. In addition to anti-microbial therapies, other innate immune stimuli may suppress pro-inflammatory signals and help to break the vicious circle of cutaneous inflammation. To elucidate further these different interactions of the skin immune system and microbes in atopic dermatitis, clinical studies and further efforts in basic research are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648910     DOI: 10.2340/00015555-0047

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  13 in total

Review 1.  [Outside-in. Probiotic topical agents].

Authors:  T Volz; T Biedermann
Journal:  Hautarzt       Date:  2009-10       Impact factor: 0.751

2.  Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis.

Authors:  Jacquelyn Levin; Sheila Fallon Friedlander; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-12

Review 3.  [The role of the innate immune system in atopic dermatitis].

Authors:  T Volz; S Kaesler; Y Skabytska; T Biedermann
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

Review 4.  How human microbiome talks to health and disease.

Authors:  Jing Cong; Xiaochun Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-22       Impact factor: 3.267

Review 5.  The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.

Authors:  Yuliya Skabytska; Susanne Kaesler; Thomas Volz; Tilo Biedermann
Journal:  Semin Immunopathol       Date:  2015-11-16       Impact factor: 9.623

6.  Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.

Authors:  Mercedes E Gonzalez; Julie V Schaffer; Seth J Orlow; Zhan Gao; Huilin Li; Alexander V Alekseyenko; Martin J Blaser
Journal:  J Am Acad Dermatol       Date:  2016-09       Impact factor: 11.527

7.  Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells.

Authors:  Thomas Volz; Yuliya Skabytska; Emmanuella Guenova; Ko-Ming Chen; Julia-Stefanie Frick; Carsten J Kirschning; Susanne Kaesler; Martin Röcken; Tilo Biedermann
Journal:  J Invest Dermatol       Date:  2013-06-28       Impact factor: 8.551

Review 8.  [Microbiome, atopic eczema and blockade of type 2 immunity].

Authors:  M Köberle; T Biedermann
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 9.  Regulation of T Cell Immunity in Atopic Dermatitis by Microbes: The Yin and Yang of Cutaneous Inflammation.

Authors:  Tilo Biedermann; Yuliya Skabytska; Susanne Kaesler; Thomas Volz
Journal:  Front Immunol       Date:  2015-07-13       Impact factor: 7.561

10.  Cutaneous bacteria induce immunosuppression.

Authors:  Yuliya Skabytska; Tilo Biedermann
Journal:  Oncotarget       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.